Carbubarb
![]() | |
Clinical data | |
---|---|
Trade names | Nogexan |
ATC code | none |
Identifiers | |
| |
Synonyms | Carbubarbital |
CAS Number |
960-05-4 ![]() |
PubChem (CID) | 13743 |
ChemSpider |
13148 ![]() |
UNII |
SIW4YR11ST ![]() |
ChEMBL |
CHEMBL2104020 ![]() |
Chemical and physical data | |
Formula | C11H17N3O5 |
Molar mass | 271.270 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Carbubarb (Carbubarbital, trade name Nogexan) is a carbamate-substituted barbiturate derivative, which has sedative effects.[1]
References
- ↑ US patent 4428887, Tou, J. S. & Schleppnik, A. A., "Method of producing mono-substituted terminal diesters", issued 1984-01-31, assigned to Monsanto
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids | |
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: GABAergics |
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.